Can Patients with HER2-Low Breast Cancer Benefit from Anti-HER2 Therapies? A Review

por Wang, Jin, Liao, Dongying, Zhang, Xuemin, Miao, Changhong, Chen, Kuang
Publicado 2023

Full-Length Transcriptome Survey and Expression Analysis of Cassia obtusifolia to Discover Putative Genes Related to Aurantio-Obtusin Biosynthesis, Seed Formation and Development,...

por Deng, Yin, Zheng, Hui, Yan, Zicheng, Liao, Dongying, Li, Chaolin, Zhou, Jiayu, Liao, Hai
Publicado 2018

Advances in Immunotherapy of Malignant Pleural Mesothelioma

por Liao, Dongying, Yu, Yongchao, Mei, Qingyun, Wang, Ziwei, Li, Xiaojiang, Jia, Yingjie, Kong, Fanming
Publicado 2021

Non-Small Cell Lung Cancer: Challenge and Improvement of Immune Drug Resistance

por Kong, Fanming, Wang, Ziwei, Liao, Dongying, Zuo, Jinhui, Xie, Hongxia, Li, Xiaojiang, Jia, Yingjie
Publicado 2021

Advances in Antibody-Drug Conjugates in the Treatment of HER2-Positive Breast Cancer

por Yu, Yongchao, Wang, Jin, Liao, Dongying, Zhang, Dou, Li, Xiaojiang, Jia, Yingjie, Kong, Fanming
Publicado 2022

Research Progress of Antibody–Drug Conjugate Therapy for Advanced Gastric Cancer

por Wang, Na, Mei, Qingyun, Wang, Ziwei, Zhao, Lu, Zhang, Dou, Liao, Dongying, Zuo, Jinhui, Xie, Hongxia, Jia, Yingjie, Kong, Fanming
Publicado 2022

Research Progress on RET Fusion in Non-Small-Cell Lung Cancer

por Zhao, Lu, Mei, Qingyun, Yu, Yongchao, Wang, Na, Zhang, Dou, Liao, Dongying, Zuo, Jinhui, Xie, Hongxia, Jia, Yingjie, Kong, Fanming
Publicado 2022